A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/53 (2006.01) A61K 31/505 (2006.01) A61P 25/00 (2006.01) A61P 25/08 (2006.01) A61P 25/22 (2006.01) A61P 25/24 (2006.01)
Patent
CA 2676357
The present invention relates to pharmaceutical compositions comprising an NK1 receptor antagonist and a sodium channel blocker, wherein at least one of them is at subtherapeutic dose, as a combined preparation for simultaneous or sequential administration, and to the use of such compositions in the treatment of certain disorders, including epilepsy, mood disorders and pain.
L'invention concerne des compositions pharmaceutiques contenant un antagoniste du récepteur de NK1 et un bloqueur de canal sodique, au moins l'un d'eux à dose sub-thérapeutique, en tant que préparation combinée pour une administration simultanée ou séquentielle, ainsi que l'utilisation de ces compositions dans le traitement de certains troubles, notamment l'épilepsie, les troubles de l'humeur et la douleur.
Alvaro Giuseppe
Large Charles
Glaxo Group Limited
Gowling Lafleur Henderson Llp
LandOfFree
Pharmaceutical compositions comprising 3, 5-diamin0-6- (2,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions comprising 3, 5-diamin0-6- (2,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising 3, 5-diamin0-6- (2,... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1917758